The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Self-citationCancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Clinicopathologic Features of <EMPH TYPE="ITAL">BRCA</EMPH>-Linked and Sporadic Ovarian Cancer
Boyd, J. (2000) · JAMA · doi:10.1001/jama.283.17.2260 · Cited by 536
Ford, D., Easton, D. F., & Peto, J. (1995) · Europe PMC (PubMed Central) · Cited by 528
Gayther, S. A., Warren, W., Mazoyer, S., Russell, P. A., Harrington, P. A., Chiano, M., Seal, S., Hamoudi, R., van Rensburg, E. J., Dunning, A. M., et al. (1995) · Nature Genetics · doi:10.1038/ng1295-428 · Cited by 496
Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Frank, T. S., Manley, S. A., Olopade, O. I., Cummings, S., Garber, J. E., Bernhardt, B., Antman, K., Russo, D., Wood, M. E., Mullineau, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2417 · Cited by 455
Whittemore, A. S., Gong, G. D., & Itnyre, J. (1997) · PubMed · Cited by 383
Shattuck-Eidens, D. (1997) · JAMA · doi:10.1001/jama.1997.03550150046034 · Cited by 374
Tumour biological features of BRCA1-induced breast and ovarian cancer
Jóhannsson, Ó. T., Idvall, I., Anderson, C., Borg, Å., Barkardóttir, R. B., Egilsson, V., & Olsson, H. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)89007-7 · Cited by 345
Shattuck-Eidens, D. M. (1995) · JAMA · doi:10.1001/jama.273.7.535 · Cited by 327
Levy‐Lahad, E., Catane, R., Eisenberg, S., Kaufman, B., Hornreich, G., Lishinsky, E., Shohat, M., Weber, B., Beller, U., Lahad, A., et al. (1997) · Europe PMC (PubMed Central) · Cited by 316
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
Moslehi, R., Chu, W., Karlan, B., Fishman, D., Risch, H., Fields, A., Smotkin, D., Ben-David, Y., Rosenblatt, J., Russo, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302853 · Cited by 314
Self-citationFrequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families
Tonin, P., Weber, B., Offit, K., Couch, F., Rebbeck, T. R., Neuhausen, S., Godwin, A. K., Daly, M., Wagner-Costalos, J., Berman, D., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1179 · Cited by 313
Self-citationMutation analysis of the BRCA2 gene in 49 site–specific breast cancer families
Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C., Moslehi, R., Dion, F., et al. (1996) · Nature Genetics · doi:10.1038/ng0596-120 · Cited by 257
Self-citationRisch, H. A., Marrett, L. D., Jain, M., & Howe, G. R. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008937 · Cited by 257
Self-citationShattuck-Eidens, D. (1995) · JAMA · doi:10.1001/jama.1995.03520310033026 · Cited by 246
Contribution of BRCA1 Mutations to Ovarian Cancer
Stratton, J. F., Gayther, S. A., Russell, P., Dearden, J., Gore, M., Blake, P., Easton, D., & Ponder, B. A. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361602 · Cited by 237
Risk models for familial ovarian and breast cancer
Antoniou, A. C., Gayther, S. A., Stratton, J. F., Ponder, B. A. J., & Easton, D. F. (2000) · Genetic Epidemiology · Cited by 192
Rubin, S. C., Blackwood, M. A., Bandera, C., Behbakht, K., Benjamin, I., Rebbeck, T. R., & Boyd, J. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70476-4 · Cited by 179
Founder BRCA1 and BRCA2 Mutations in French Canadian Breast and Ovarian Cancer Families
Tonin, P. N., Mes-Masson, A.-M., Futreal, P. A., Morgan, K., Mahon, M., Foulkes, W. D., Cole, D. E. C., Provencher, D., Ghadirian, P., & Narod, S. A. (1998) · The American Journal of Human Genetics · doi:10.1086/302099 · Cited by 165
Self-citationUnger, M. A., Nathanson, K. L., Calzone, K., Antin-Ozerkis, D. E., Shih, H. A., Martin, A., Lenoir, G., Mazoyer, S., & Weber, B. L. (2000) · The American Journal of Human Genetics · doi:10.1086/303076 · Cited by 157
The Kin-Cohort Study for Estimating Penetrance
Wacholder, S., Hartge, P. A., Struewing, J. P., et al. (1998) · American Journal of Epidemiology · doi:10.1093/aje/148.7.623 · Cited by 143
An Alu-Mediated 6-kb Duplication in the BRCA1 Gene: A New Founder Mutation?
Puget, N., Sinilnikova, O. M., Stoppa‐Lyonnet, D., Audoynaud, C., Pagès-Berhouet, S., Lynch, H. T., Goldgar, D. E., Lenoir, G., & Mazoyer, S. (1999) · The American Journal of Human Genetics · doi:10.1086/302211 · Cited by 129
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Foster, K. A., Harrington, P. A., Kerr, J., Russell, P. A., DiCioccio, R. A., Scott, I., Jacobs, I. J., Chenevix‐Trench, G., Ponder, B. A. J., & Gayther, S. A. (1996) · PubMed · Cited by 119
Shattuck-Eidens, D., McClure, M., Simard, J., Labrie, F., Narod, S., Couch, F. J., Hoskins, K. F., Weber, B., Castilla, L. H., & Erdos, M. (1995) · PubMed · Cited by 116
Self-citationMutations of the BRCA2 gene in ovarian carcinomas.
Takahashi, H., Chiu, H. C., Bandera, C. A., Behbakht, K., Liu, P. C., Couch, F. J., Weber, B. L., LiVolsi, V. A., Furusato, M., Rebane, B. A., et al. (1996) · PubMed · Cited by 115
Prevalence of founderBRCA1 andBRCA2 mutations among breast and ovarian cancer patients in hungary
van der Looij, M., Szabo, C., Besznyák, I., Liszka, G., Csókay, B., Pulay, T., Tóth, J., Devilee, P., King, M., & Oláh, E. (2000) · International Journal of Cancer · Cited by 104
Mazoyer, S. (2000) · The American Journal of Human Genetics · doi:10.1086/302974 · Cited by 99
Matsushima, M., Kobayashi, K., Eml, M., Saito, J., Suzumori, K., & Nakamura, Y. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.10.1953 · Cited by 91
The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.
Stratton, J., Thompson, D., Bobrow, L., Dalal, N., Gore, M., Bishop, D., Scott, I. A., Evans, G., Daly, P., Easton, D., et al. (1999) · American Journal of Human Genetics · doi:10.1086/302671 · Cited by 84
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
Narod, S. A., Ford, D., Devilee, P., Barkardottir, R. B., Eyfjord, J. E., Lenoir, G., Serova, O., Easton, D. F., & Goldgar, D. E. (1995) · Europe PMC (PubMed Central) · Cited by 75
Self-citationBRCA1 and BRCA2 have a limited role in familial prostate cancer.
Sinclair, C. S., Berry, R. M., Schaid, D. J., Thibodeau, S. N., & Couch, F. J. (2000) · PubMed · Cited by 69
Rates of Jewish Ancestral Mutations in BRCAI and BRCA2 in Borderline Ovarian Tumors
Gotlieb, W. H., Ben‐Baruch, G., Friedman, E., Bar-Sade, R. B., Сергеевна, К. А., Hirsh‐Yechezkel, G., Modan, B., Novikov, I., Davidson, B., Kopolovic, J., et al. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.995 · Cited by 50
Cited by
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationBreast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Cancer Incidence in BRCA1 Mutation Carriers
Thompson, D. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.18.1358 · Cited by 1,096
Metadata
- Authors
- Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., Fan, I., Wong, B., & Narod, S. A.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 68
- Issue
- 3
- Pages
- 700-710
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2025460005
- Cited by
- 986
- References
- 36
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.